Nexviazyme™
Nexviazyme is used to treat Pompe disease, a rare genetic disease in which the level of an enzyme called acid alfa-glucosidase is missing or is lower than in healthy individuals. This enzyme helps the body control levels of glycogen (a type of carbohydrate).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER: Sanofi |
CLASS: Enzymes, Metabolic |
WHAT IT TREATS: Pompe disease |
PRESCRIBED BY: Cardiologists |
HOW ADMINISTERED: Intravenous infusion |
FREQUENCY: Every two weeks |
Length of infusion: 4-7 hours |
FOR MORE INFORMATION: |